A detailed history of Aisling Capital Management LP transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Aisling Capital Management LP holds 2,834,910 shares of ELEV stock, worth $1.67 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
2,834,910
Previous 2,834,910 -0.0%
Holding current value
$1.67 Million
Previous $7.65 Million 77.79%
% of portfolio
0.7%
Previous 3.35%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 06, 2021

BUY
$11.44 - $13.57 $32.4 Million - $38.5 Million
2,834,910 New
2,834,910 $38.5 Million

Others Institutions Holding ELEV

About Elevation Oncology, Inc.


  • Ticker ELEV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,300,900
  • Market Cap $13.7M
  • Description
  • Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...
More about ELEV
Track This Portfolio

Track Aisling Capital Management LP Portfolio

Follow Aisling Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aisling Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Aisling Capital Management LP with notifications on news.